Effects of GLP-1 RAs on Human Lactation Outcomes
Eligible age
All ages
Accepts
Women
Locations
1 state
Healthy volunteers
Yes
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
There is increasing interest in using GLP-1 Receptor Agonist (GLP-1 RA) medications after pregnancy. This study is designed to determine if these medications affect breastmilk production or the nutritional makeup of breastmilk. The main questions the study will address are: * Does GLP-1 RA-induced weight loss increase or decrease breastmilk production? * Does GLP-1 RA-induced weight loss affect the nutritional composition of milk, including milk fat content? Researchers will assess milk production rates before and after mothers begin taking injected GLP-1 RA medications to decrease their body weight. Weight loss will be confirmed with 7-day body weight averages. Participants will: * Weigh themselves and report measurements daily. * Participate in 2-3 morning study visits over approx. 2.5-4.5 months (approx. 3-3.5hrs each). During each visit, participants will: * Use a study provided breastpump to express milk 3 times hourly for measurement of hourly milk production. * Provide 1-3 oz of milk for further study. * Answer questions about breastfeeding patterns.
Sponsor: University of Colorado, Denver
You may qualify if…
- ✓ Breastfeeding mothers of single or multiple infants.
- ✓ Milk removal at least 4x daily
- ✓ Eligible for a GLP-1 RA administered subcutaneously (oral GLP-1 RAs contain absorption enhancers, which may drive accumulation in milk)
- ✓ Access to a breastpump, if needed for maintaining breastfeeding behaviors.
- ✓ Willingness to provide 1-3 oz of breastmilk per study visit.
- ✓ Willingness to track and report body weight daily.
- ✓ Willingness to maintain breastfeeding behaviors for the duration of the study.
You may not qualify if…
- ✕ Currently taking GLP-1 RA medication or other weight loss medication
- ✕ Induced lactation, due to unknowns regarding the durability of the mammary gland's milk production after exogenous stimulation.
Where it's recruiting
Aurora
Source: ClinicalTrials.gov · NCT07720414 · last updated 2026-07-22